Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For patients with epilepsy:
- You have epilepsy that has not been controlled by medications (drug-resistant focal epilepsy)
- You are between 3 and 19 years old
- You are already planned to have a two-stage epilepsy surgery that involves placing electrodes on the surface of the brain
For healthy volunteers (comparison group):
- You are between 5 and 19 years old
- You do not have any problems with thinking, movement, language, or behavior
- Your brain MRI scan has been reviewed and found to be normal
Who may not be able to join:
- You were born prematurely or had a lack of oxygen to the brain around the time of birth
- You have weakness or paralysis on one side of your body
- You have physical features that suggest a specific genetic or developmental syndrome (confirm with trial site)
- You have been diagnosed with autism, tic disorders, obsessive-compulsive disorder, or another developmental or psychiatric condition that started before your seizures began
- Your MRI shows very large or severe brain abnormalities that would interfere with the brain scans used in this study (confirm with trial site)
- You have a history of feeling very anxious or panicked in small, enclosed spaces (claustrophobia)
- Your MRI scan was not usable due to too much head movement during the scan
- You are not able to speak English
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 313-993-0258
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Accuracy of DCNN tract classification for detection of ESM-defined eloquent white matter pathways in healthy controls; Accuracy of DCNN tract classification for detection of ESM-defined eloquent area that will be acquired a month after the DCNN tract classification in children with drug-resistant epilepsy; Accuracy of DCNN tract classification for prediction of eloquent white matter pathways providing no postoperative deficits that will be assessed at 1.5 years after surgery; Accuracy of DCNN tract classification combined with Kalman analysis to predict optimal margin balancing maximal seizure...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.